US Patent:
20120122887, May 17, 2012
Inventors:
Rolf-Stefan BRICKL - Warthausen, DE
Shirlynn CHEN - Somers NY, US
Jihchin CHUNG - Princeton Junction NJ, US
Mayur Suryakant DUDHEDIA - Brookfield CT, US
Danping LI - Middlebury CT, US
Zhi-Hui LU - Newtown CT, US
Siddharthya MUJUMDAR - Auburndale MA, US
Chitra TELANG - Brookfield CT, US
Richard J. VARSOLONA - Scotch Plains NJ, US
Zeren WANG - Southbury CT, US
Assignee:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH - Ingelheim am Rhein
International Classification:
A61K 31/506
A61P 31/12
C07D 403/14
Abstract:
This invention relates to novel sodium salt forms of the following Compound (1), and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection: